Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2024 | Highlights from AAIC 2024: tau-PET harmonization and the DIAN-TU trial

Cécile Tissot • 13 Aug 2024
AAIC 2024
Alzheimer’s Disease Dementia Antibodies Gantenerumab
DIAN-TU

Cécile Tissot, PhD, University of California, Berkeley, CA, discusses highlights from this year’s AAIC meeting, including a session focused on tau-positron emission tomography (PET) harmonization in Alzheimer’s disease (AD). She also mentions the DIAN-TU trial (NCT01760005), which has shown favorable outcomes in patients treated with gantenerumab. This interview took place at the Alzheimer’s Association International Conference® (AAIC) 2024 in Philadelphia, PA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Cécile Tissot

The clinical use of tau-PET: its value and limitations
1:50
The clinical use of tau-PET: its value and limitations
Cécile Tissot • 13 Aug 2024
Improving tau-PET harmonization: the HEAD study
5:57
Improving tau-PET harmonization: the HEAD study
Cécile Tissot • 13 Aug 2024

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals